Elizabeth Bayliss
Concepts (375)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deprescriptions | 16 | 2025 | 35 | 7.810 |
Why?
| | Chronic Disease | 32 | 2024 | 1784 | 4.180 |
Why?
| | Dementia | 12 | 2025 | 252 | 3.590 |
Why?
| | Multiple Chronic Conditions | 12 | 2024 | 29 | 2.860 |
Why?
| | Cognitive Dysfunction | 7 | 2024 | 385 | 2.810 |
Why?
| | Patient Portals | 5 | 2024 | 45 | 2.530 |
Why?
| | Primary Health Care | 23 | 2025 | 1714 | 2.390 |
Why?
| | Comorbidity | 23 | 2018 | 1611 | 2.250 |
Why?
| | Patient-Centered Care | 8 | 2021 | 520 | 1.900 |
Why?
| | Patient Care Team | 9 | 2019 | 627 | 1.780 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 4 | 2024 | 251 | 1.710 |
Why?
| | Polypharmacy | 8 | 2025 | 85 | 1.640 |
Why?
| | Aged | 70 | 2025 | 23729 | 1.550 |
Why?
| | Electronic Health Records | 8 | 2025 | 1036 | 1.490 |
Why?
| | Aged, 80 and over | 34 | 2025 | 7569 | 1.400 |
Why?
| | Potentially Inappropriate Medication List | 4 | 2024 | 16 | 1.360 |
Why?
| | Delivery of Health Care, Integrated | 6 | 2021 | 256 | 1.340 |
Why?
| | Health Status | 8 | 2019 | 781 | 1.330 |
Why?
| | Physicians, Primary Care | 7 | 2019 | 232 | 1.300 |
Why?
| | Quality of Life | 16 | 2022 | 2868 | 1.240 |
Why?
| | Safety-net Providers | 3 | 2021 | 117 | 1.170 |
Why?
| | Depressive Disorder | 4 | 2012 | 380 | 1.110 |
Why?
| | Delivery of Health Care | 8 | 2021 | 939 | 1.110 |
Why?
| | Continuity of Patient Care | 4 | 2019 | 278 | 1.080 |
Why?
| | Inappropriate Prescribing | 2 | 2024 | 55 | 1.080 |
Why?
| | Communication | 8 | 2025 | 869 | 1.010 |
Why?
| | Quality of Health Care | 4 | 2021 | 627 | 1.010 |
Why?
| | Self Care | 6 | 2012 | 375 | 1.000 |
Why?
| | Female | 84 | 2025 | 72840 | 1.000 |
Why?
| | Male | 82 | 2025 | 67361 | 0.990 |
Why?
| | Polypharmacology | 1 | 2025 | 2 | 0.960 |
Why?
| | Humans | 118 | 2025 | 136783 | 0.950 |
Why?
| | Mental Disorders | 6 | 2020 | 1075 | 0.880 |
Why?
| | Chronic Pain | 2 | 2022 | 255 | 0.880 |
Why?
| | Caregivers | 13 | 2025 | 873 | 0.870 |
Why?
| | Health Services | 2 | 2017 | 103 | 0.850 |
Why?
| | Benzodiazepines | 1 | 2024 | 152 | 0.840 |
Why?
| | Gastric Bypass | 2 | 2014 | 118 | 0.790 |
Why?
| | Attitude of Health Personnel | 5 | 2017 | 1157 | 0.790 |
Why?
| | United States | 32 | 2025 | 14660 | 0.770 |
Why?
| | Health Status Indicators | 2 | 2014 | 171 | 0.760 |
Why?
| | Retrospective Studies | 30 | 2024 | 15564 | 0.730 |
Why?
| | Qualitative Research | 13 | 2025 | 1359 | 0.730 |
Why?
| | Cholinergic Antagonists | 2 | 2019 | 29 | 0.720 |
Why?
| | Food Supply | 1 | 2021 | 80 | 0.690 |
Why?
| | Health Plan Implementation | 2 | 2019 | 137 | 0.690 |
Why?
| | Colorado | 16 | 2025 | 4491 | 0.670 |
Why?
| | Self Efficacy | 3 | 2019 | 394 | 0.660 |
Why?
| | Cohort Studies | 19 | 2025 | 5718 | 0.650 |
Why?
| | Patient Reported Outcome Measures | 4 | 2019 | 400 | 0.640 |
Why?
| | Advance Directives | 1 | 2020 | 70 | 0.630 |
Why?
| | Mental Health Services | 3 | 2019 | 414 | 0.630 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 1042 | 0.630 |
Why?
| | Medicare Part D | 2 | 2010 | 25 | 0.620 |
Why?
| | Hospitalization | 7 | 2024 | 2195 | 0.610 |
Why?
| | Middle Aged | 42 | 2025 | 33200 | 0.600 |
Why?
| | Practice Guidelines as Topic | 3 | 2021 | 1568 | 0.590 |
Why?
| | Telemedicine | 4 | 2024 | 847 | 0.590 |
Why?
| | Documentation | 1 | 2020 | 189 | 0.580 |
Why?
| | Delayed Diagnosis | 1 | 2018 | 91 | 0.580 |
Why?
| | Health Services Needs and Demand | 3 | 2015 | 268 | 0.580 |
Why?
| | Diabetic Neuropathies | 2 | 2016 | 93 | 0.570 |
Why?
| | Hypolipidemic Agents | 3 | 2017 | 92 | 0.560 |
Why?
| | Specialization | 2 | 2017 | 143 | 0.540 |
Why?
| | Patient Acceptance of Health Care | 4 | 2021 | 806 | 0.530 |
Why?
| | Time-to-Treatment | 1 | 2018 | 203 | 0.530 |
Why?
| | Maryland | 4 | 2025 | 55 | 0.510 |
Why?
| | Health Maintenance Organizations | 6 | 2012 | 96 | 0.510 |
Why?
| | Medication Adherence | 4 | 2022 | 468 | 0.510 |
Why?
| | Medically Uninsured | 1 | 2017 | 129 | 0.500 |
Why?
| | Practice Patterns, Physicians' | 3 | 2017 | 1294 | 0.500 |
Why?
| | Patient Satisfaction | 4 | 2019 | 650 | 0.500 |
Why?
| | Health Knowledge, Attitudes, Practice | 6 | 2021 | 1323 | 0.500 |
Why?
| | Medicaid | 2 | 2022 | 433 | 0.490 |
Why?
| | Diabetes Mellitus, Type 2 | 7 | 2023 | 2512 | 0.490 |
Why?
| | Healthcare Disparities | 2 | 2021 | 649 | 0.490 |
Why?
| | Patients | 2 | 2021 | 173 | 0.490 |
Why?
| | Adult | 34 | 2024 | 37616 | 0.480 |
Why?
| | Self Report | 6 | 2024 | 825 | 0.480 |
Why?
| | Health Promotion | 1 | 2021 | 736 | 0.470 |
Why?
| | Antihypertensive Agents | 5 | 2019 | 488 | 0.470 |
Why?
| | Sickness Impact Profile | 2 | 2005 | 56 | 0.460 |
Why?
| | Pain Management | 2 | 2015 | 347 | 0.460 |
Why?
| | Gastroplasty | 1 | 2014 | 30 | 0.460 |
Why?
| | Bariatric Surgery | 2 | 2015 | 214 | 0.450 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2015 | 103 | 0.450 |
Why?
| | Hypoglycemic Agents | 5 | 2019 | 1281 | 0.440 |
Why?
| | Diabetes Mellitus | 7 | 2017 | 1033 | 0.430 |
Why?
| | Surveys and Questionnaires | 17 | 2022 | 5749 | 0.430 |
Why?
| | Drug Utilization | 2 | 2012 | 170 | 0.430 |
Why?
| | Neuralgia | 1 | 2015 | 133 | 0.420 |
Why?
| | Hypertension | 7 | 2019 | 1284 | 0.420 |
Why?
| | Sleep Deprivation | 1 | 2015 | 174 | 0.410 |
Why?
| | Focus Groups | 5 | 2020 | 508 | 0.410 |
Why?
| | Morbidity | 2 | 2012 | 322 | 0.410 |
Why?
| | Laparoscopy | 2 | 2014 | 464 | 0.410 |
Why?
| | Postoperative Care | 1 | 2015 | 257 | 0.410 |
Why?
| | Health Services Accessibility | 3 | 2017 | 976 | 0.410 |
Why?
| | Comparative Effectiveness Research | 1 | 2014 | 150 | 0.400 |
Why?
| | Socioeconomic Factors | 7 | 2020 | 1281 | 0.400 |
Why?
| | Preoperative Care | 1 | 2015 | 356 | 0.390 |
Why?
| | Colorectal Neoplasms | 3 | 2014 | 792 | 0.390 |
Why?
| | Morphine | 1 | 2013 | 160 | 0.390 |
Why?
| | Osteoarthritis | 3 | 2008 | 183 | 0.370 |
Why?
| | Cross-Sectional Studies | 14 | 2023 | 5417 | 0.370 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2012 | 46 | 0.370 |
Why?
| | Cluster Analysis | 2 | 2020 | 495 | 0.360 |
Why?
| | International Classification of Diseases | 1 | 2012 | 131 | 0.350 |
Why?
| | Psychotherapy | 1 | 2012 | 163 | 0.350 |
Why?
| | Referral and Consultation | 1 | 2017 | 777 | 0.350 |
Why?
| | Severity of Illness Index | 3 | 2015 | 2831 | 0.350 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2013 | 442 | 0.340 |
Why?
| | Antidepressive Agents | 1 | 2012 | 235 | 0.340 |
Why?
| | Office Visits | 3 | 2018 | 90 | 0.340 |
Why?
| | Obesity | 2 | 2014 | 2975 | 0.340 |
Why?
| | Physician-Patient Relations | 6 | 2019 | 544 | 0.330 |
Why?
| | Prostatic Neoplasms | 2 | 2014 | 1031 | 0.330 |
Why?
| | Quality Improvement | 5 | 2020 | 1152 | 0.330 |
Why?
| | Models, Statistical | 1 | 2014 | 658 | 0.320 |
Why?
| | Risk Assessment | 8 | 2024 | 3429 | 0.320 |
Why?
| | Patient Preference | 3 | 2022 | 190 | 0.320 |
Why?
| | Vaccination Refusal | 2 | 2021 | 70 | 0.320 |
Why?
| | Multimorbidity | 2 | 2021 | 47 | 0.310 |
Why?
| | Perception | 3 | 2020 | 356 | 0.310 |
Why?
| | Patient Participation | 5 | 2022 | 416 | 0.310 |
Why?
| | Research | 3 | 2018 | 445 | 0.310 |
Why?
| | Stakeholder Participation | 2 | 2020 | 75 | 0.300 |
Why?
| | Neoplasms | 3 | 2014 | 2644 | 0.300 |
Why?
| | Medicare | 6 | 2023 | 747 | 0.300 |
Why?
| | Analgesics, Opioid | 2 | 2014 | 991 | 0.300 |
Why?
| | Emergency Service, Hospital | 3 | 2015 | 2050 | 0.290 |
Why?
| | Health Personnel | 3 | 2019 | 698 | 0.280 |
Why?
| | Health Services for the Aged | 1 | 2008 | 73 | 0.280 |
Why?
| | Depressive Disorder, Major | 1 | 2012 | 360 | 0.280 |
Why?
| | Delphi Technique | 4 | 2018 | 273 | 0.280 |
Why?
| | Geriatrics | 1 | 2008 | 89 | 0.270 |
Why?
| | Disease Progression | 2 | 2015 | 2750 | 0.270 |
Why?
| | Cost of Illness | 2 | 2008 | 300 | 0.270 |
Why?
| | Glomerular Filtration Rate | 1 | 2011 | 744 | 0.270 |
Why?
| | Kidney Diseases | 1 | 2011 | 406 | 0.260 |
Why?
| | Breast Neoplasms | 1 | 2018 | 2239 | 0.250 |
Why?
| | Psychometrics | 3 | 2018 | 721 | 0.250 |
Why?
| | Accidental Falls | 2 | 2019 | 188 | 0.250 |
Why?
| | Telephone | 2 | 2017 | 170 | 0.240 |
Why?
| | Pain Measurement | 2 | 2018 | 522 | 0.230 |
Why?
| | Disease Management | 4 | 2017 | 623 | 0.220 |
Why?
| | Patient Compliance | 1 | 2008 | 576 | 0.220 |
Why?
| | Nomograms | 2 | 2014 | 54 | 0.220 |
Why?
| | Parents | 3 | 2021 | 1355 | 0.220 |
Why?
| | Single-Payer System | 1 | 2003 | 2 | 0.220 |
Why?
| | National Health Insurance, United States | 1 | 2003 | 4 | 0.220 |
Why?
| | Managed Care Programs | 2 | 2014 | 129 | 0.210 |
Why?
| | Pragmatic Clinical Trials as Topic | 2 | 2022 | 64 | 0.210 |
Why?
| | Multivariate Analysis | 5 | 2013 | 1513 | 0.210 |
Why?
| | Death | 2 | 2022 | 118 | 0.210 |
Why?
| | Natural Language Processing | 1 | 2025 | 93 | 0.210 |
Why?
| | Dyslipidemias | 3 | 2019 | 176 | 0.210 |
Why?
| | Cardiovascular Diseases | 2 | 2014 | 2108 | 0.210 |
Why?
| | Vaccination | 3 | 2021 | 1378 | 0.210 |
Why?
| | Health Services Research | 3 | 2017 | 400 | 0.210 |
Why?
| | Insurance Coverage | 2 | 2018 | 228 | 0.200 |
Why?
| | Interdisciplinary Communication | 2 | 2014 | 192 | 0.200 |
Why?
| | Health Care Reform | 1 | 2003 | 102 | 0.200 |
Why?
| | Data Collection | 1 | 2005 | 664 | 0.200 |
Why?
| | Attitude | 2 | 2021 | 259 | 0.190 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2024 | 179 | 0.190 |
Why?
| | Prognosis | 4 | 2014 | 4018 | 0.190 |
Why?
| | Pharmacists | 1 | 2025 | 260 | 0.190 |
Why?
| | Asthma | 2 | 2016 | 2290 | 0.190 |
Why?
| | Physicians | 2 | 2023 | 897 | 0.190 |
Why?
| | Survival Rate | 3 | 2014 | 1969 | 0.180 |
Why?
| | Proxy | 1 | 2021 | 28 | 0.180 |
Why?
| | Interviews as Topic | 4 | 2024 | 766 | 0.180 |
Why?
| | Information Storage and Retrieval | 1 | 2021 | 117 | 0.170 |
Why?
| | Patient Care Management | 1 | 2020 | 56 | 0.170 |
Why?
| | Clergy | 1 | 2020 | 11 | 0.170 |
Why?
| | Age Factors | 6 | 2019 | 3290 | 0.170 |
Why?
| | Pharmaceutical Preparations | 1 | 2022 | 179 | 0.160 |
Why?
| | Longitudinal Studies | 4 | 2018 | 2847 | 0.160 |
Why?
| | Fee-for-Service Plans | 2 | 2014 | 85 | 0.160 |
Why?
| | Anti-Vaccination Movement | 1 | 2019 | 3 | 0.160 |
Why?
| | Health Surveys | 3 | 2012 | 517 | 0.160 |
Why?
| | Southwestern United States | 1 | 2019 | 90 | 0.160 |
Why?
| | Urban Health Services | 1 | 2019 | 63 | 0.160 |
Why?
| | Religion | 1 | 2019 | 70 | 0.150 |
Why?
| | Follow-Up Studies | 4 | 2017 | 5115 | 0.150 |
Why?
| | Residence Characteristics | 1 | 2022 | 354 | 0.150 |
Why?
| | Interprofessional Relations | 2 | 2013 | 280 | 0.150 |
Why?
| | Sulfonylurea Compounds | 1 | 2019 | 48 | 0.150 |
Why?
| | Time Factors | 5 | 2018 | 6792 | 0.150 |
Why?
| | Child, Preschool | 5 | 2021 | 11069 | 0.150 |
Why?
| | Attitude to Health | 2 | 2015 | 439 | 0.150 |
Why?
| | Comprehensive Health Care | 2 | 2017 | 22 | 0.150 |
Why?
| | Contraindications, Drug | 1 | 2018 | 8 | 0.140 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2018 | 217 | 0.140 |
Why?
| | Research Design | 2 | 2024 | 1107 | 0.140 |
Why?
| | Medical Informatics | 1 | 2019 | 100 | 0.140 |
Why?
| | Mastectomy | 1 | 2018 | 136 | 0.140 |
Why?
| | Vaccines | 2 | 2020 | 406 | 0.140 |
Why?
| | Models, Theoretical | 1 | 2021 | 572 | 0.140 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2018 | 390 | 0.140 |
Why?
| | Prospective Studies | 5 | 2023 | 7583 | 0.130 |
Why?
| | SEER Program | 2 | 2014 | 218 | 0.130 |
Why?
| | Independent Living | 1 | 2018 | 103 | 0.130 |
Why?
| | Young Adult | 6 | 2016 | 13126 | 0.130 |
Why?
| | Case Management | 1 | 2017 | 65 | 0.130 |
Why?
| | Electronics | 1 | 2017 | 75 | 0.130 |
Why?
| | General Practice | 1 | 2016 | 29 | 0.130 |
Why?
| | Logistic Models | 5 | 2013 | 2060 | 0.130 |
Why?
| | Blood Pressure | 3 | 2019 | 1772 | 0.130 |
Why?
| | Medication Therapy Management | 1 | 2017 | 75 | 0.130 |
Why?
| | Influenza Vaccines | 1 | 2021 | 539 | 0.130 |
Why?
| | Schools | 1 | 2019 | 462 | 0.120 |
Why?
| | Health Care Costs | 1 | 2019 | 385 | 0.120 |
Why?
| | Patient Outcome Assessment | 1 | 2017 | 130 | 0.120 |
Why?
| | Validation Studies as Topic | 1 | 2015 | 22 | 0.120 |
Why?
| | Adolescent | 6 | 2015 | 21463 | 0.120 |
Why?
| | Body Mass Index | 2 | 2014 | 2364 | 0.120 |
Why?
| | Metformin | 1 | 2019 | 329 | 0.120 |
Why?
| | Risk Factors | 7 | 2024 | 10331 | 0.120 |
Why?
| | Clinical Decision-Making | 1 | 2018 | 318 | 0.120 |
Why?
| | Influenza, Human | 1 | 2021 | 624 | 0.110 |
Why?
| | Neoplasm Staging | 1 | 2018 | 1373 | 0.110 |
Why?
| | Hyperlipidemias | 2 | 2012 | 120 | 0.110 |
Why?
| | Infant | 2 | 2021 | 9442 | 0.110 |
Why?
| | United States Agency for Healthcare Research and Quality | 1 | 2014 | 10 | 0.110 |
Why?
| | Proportional Hazards Models | 2 | 2015 | 1260 | 0.110 |
Why?
| | California | 3 | 2024 | 424 | 0.110 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2022 | 840 | 0.110 |
Why?
| | Health Priorities | 1 | 2014 | 44 | 0.110 |
Why?
| | Health Education | 1 | 2016 | 337 | 0.100 |
Why?
| | Child | 5 | 2021 | 21968 | 0.100 |
Why?
| | Cooperative Behavior | 2 | 2014 | 443 | 0.100 |
Why?
| | Age Distribution | 1 | 2014 | 391 | 0.100 |
Why?
| | Activities of Daily Living | 2 | 2008 | 412 | 0.100 |
Why?
| | Terminally Ill | 1 | 2013 | 37 | 0.100 |
Why?
| | Guideline Adherence | 1 | 2017 | 543 | 0.100 |
Why?
| | Lung Diseases, Obstructive | 1 | 2012 | 50 | 0.100 |
Why?
| | Postoperative Period | 1 | 2013 | 343 | 0.100 |
Why?
| | Decision Making | 1 | 2019 | 896 | 0.100 |
Why?
| | Program Evaluation | 1 | 2017 | 886 | 0.100 |
Why?
| | Information Dissemination | 1 | 2014 | 217 | 0.100 |
Why?
| | Postoperative Complications | 2 | 2014 | 2624 | 0.090 |
Why?
| | Depression | 3 | 2018 | 1402 | 0.090 |
Why?
| | Quality Assurance, Health Care | 1 | 2014 | 322 | 0.090 |
Why?
| | Secondary Prevention | 1 | 2013 | 233 | 0.090 |
Why?
| | Diabetes Complications | 1 | 2013 | 226 | 0.090 |
Why?
| | Primary Prevention | 1 | 2013 | 196 | 0.090 |
Why?
| | Obesity, Morbid | 1 | 2014 | 258 | 0.090 |
Why?
| | Insulin | 2 | 2019 | 2399 | 0.090 |
Why?
| | Anticholesteremic Agents | 1 | 2012 | 153 | 0.080 |
Why?
| | Data Mining | 1 | 2011 | 115 | 0.080 |
Why?
| | Pandemics | 3 | 2024 | 1619 | 0.080 |
Why?
| | Osteoarthritis, Knee | 1 | 2013 | 255 | 0.080 |
Why?
| | Evidence-Based Medicine | 1 | 2014 | 738 | 0.080 |
Why?
| | Weight Loss | 1 | 2015 | 775 | 0.080 |
Why?
| | Emigrants and Immigrants | 1 | 2012 | 137 | 0.080 |
Why?
| | Databases, Factual | 2 | 2012 | 1347 | 0.080 |
Why?
| | Prescription Fees | 1 | 2008 | 4 | 0.080 |
Why?
| | Reproducibility of Results | 3 | 2019 | 3272 | 0.080 |
Why?
| | Medical Records Systems, Computerized | 2 | 2007 | 92 | 0.070 |
Why?
| | Poisson Distribution | 1 | 2008 | 72 | 0.070 |
Why?
| | Drug Utilization Review | 1 | 2008 | 56 | 0.070 |
Why?
| | Pain | 1 | 2014 | 755 | 0.070 |
Why?
| | Self Disclosure | 1 | 2008 | 63 | 0.070 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2013 | 326 | 0.070 |
Why?
| | Eligibility Determination | 1 | 2008 | 65 | 0.070 |
Why?
| | Community Health Services | 1 | 2010 | 228 | 0.070 |
Why?
| | Autoimmune Diseases | 1 | 2012 | 459 | 0.070 |
Why?
| | Insurance, Pharmaceutical Services | 1 | 2007 | 22 | 0.070 |
Why?
| | Incidence | 2 | 2014 | 2788 | 0.070 |
Why?
| | Treatment Outcome | 4 | 2016 | 10764 | 0.070 |
Why?
| | Immunoglobulin G | 1 | 2012 | 886 | 0.070 |
Why?
| | Biomedical Research | 1 | 2014 | 689 | 0.070 |
Why?
| | Treatment Refusal | 1 | 2007 | 89 | 0.070 |
Why?
| | Sex Distribution | 1 | 2007 | 376 | 0.060 |
Why?
| | Odds Ratio | 3 | 2014 | 1063 | 0.060 |
Why?
| | Opioid-Related Disorders | 1 | 2014 | 504 | 0.060 |
Why?
| | Coronary Artery Disease | 1 | 2012 | 702 | 0.060 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2023 | 3709 | 0.060 |
Why?
| | Urban Population | 2 | 2012 | 472 | 0.060 |
Why?
| | Linear Models | 1 | 2007 | 845 | 0.060 |
Why?
| | Antibodies, Monoclonal | 1 | 2012 | 1428 | 0.060 |
Why?
| | Mass Screening | 1 | 2013 | 1262 | 0.060 |
Why?
| | Chicago | 1 | 2004 | 61 | 0.060 |
Why?
| | Los Angeles | 1 | 2004 | 76 | 0.060 |
Why?
| | Contraceptives, Oral | 1 | 2024 | 43 | 0.060 |
Why?
| | Boston | 1 | 2004 | 91 | 0.060 |
Why?
| | Causality | 1 | 2024 | 127 | 0.050 |
Why?
| | Goals | 1 | 2005 | 168 | 0.050 |
Why?
| | Algorithms | 1 | 2011 | 1686 | 0.050 |
Why?
| | Self Concept | 1 | 2005 | 252 | 0.050 |
Why?
| | Choice Behavior | 1 | 2005 | 171 | 0.050 |
Why?
| | Estrogen Replacement Therapy | 1 | 2024 | 146 | 0.050 |
Why?
| | Social Support | 1 | 2007 | 615 | 0.050 |
Why?
| | Medicine | 1 | 2004 | 119 | 0.050 |
Why?
| | Regression Analysis | 1 | 2004 | 1024 | 0.050 |
Why?
| | Internet | 2 | 2019 | 648 | 0.050 |
Why?
| | Estrogens | 1 | 2024 | 367 | 0.050 |
Why?
| | Self-Management | 1 | 2024 | 166 | 0.050 |
Why?
| | Insurance Claim Review | 1 | 2021 | 62 | 0.040 |
Why?
| | Washington | 1 | 2021 | 154 | 0.040 |
Why?
| | Chi-Square Distribution | 2 | 2012 | 532 | 0.040 |
Why?
| | Housing | 1 | 2022 | 147 | 0.040 |
Why?
| | Cholesterol, LDL | 2 | 2014 | 366 | 0.040 |
Why?
| | Medical Records | 1 | 2021 | 172 | 0.040 |
Why?
| | Health Expenditures | 1 | 2022 | 184 | 0.040 |
Why?
| | Health Care Rationing | 1 | 2020 | 59 | 0.040 |
Why?
| | Assisted Living Facilities | 1 | 2020 | 18 | 0.040 |
Why?
| | Resource Allocation | 1 | 2020 | 51 | 0.040 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2020 | 128 | 0.040 |
Why?
| | Minority Groups | 1 | 2022 | 267 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1697 | 0.040 |
Why?
| | Health Behavior | 1 | 2005 | 756 | 0.040 |
Why?
| | Heart Failure | 1 | 2012 | 2228 | 0.040 |
Why?
| | Appointments and Schedules | 1 | 2019 | 89 | 0.040 |
Why?
| | Medicare Part C | 1 | 2019 | 29 | 0.040 |
Why?
| | Nursing Homes | 1 | 2020 | 167 | 0.040 |
Why?
| | Stress, Psychological | 1 | 2007 | 1098 | 0.040 |
Why?
| | Mortality | 1 | 2020 | 357 | 0.040 |
Why?
| | Reference Values | 1 | 2019 | 817 | 0.040 |
Why?
| | Social Determinants of Health | 1 | 2021 | 250 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2018 | 286 | 0.030 |
Why?
| | Intention | 1 | 2019 | 170 | 0.030 |
Why?
| | Fatigue | 1 | 2018 | 327 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2019 | 1059 | 0.030 |
Why?
| | Guidelines as Topic | 1 | 2018 | 276 | 0.030 |
Why?
| | Automation | 1 | 2016 | 95 | 0.030 |
Why?
| | Drug Interactions | 1 | 2017 | 405 | 0.030 |
Why?
| | Hospitals | 1 | 2020 | 677 | 0.030 |
Why?
| | Prevalence | 1 | 2022 | 2712 | 0.030 |
Why?
| | Sleep Wake Disorders | 1 | 2018 | 283 | 0.030 |
Why?
| | Consensus | 1 | 2018 | 679 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2017 | 584 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2007 | 1318 | 0.030 |
Why?
| | Patient Access to Records | 1 | 2013 | 20 | 0.030 |
Why?
| | ROC Curve | 1 | 2014 | 545 | 0.020 |
Why?
| | Electronic Mail | 1 | 2013 | 61 | 0.020 |
Why?
| | Remote Consultation | 1 | 2013 | 50 | 0.020 |
Why?
| | Etanercept | 1 | 2012 | 57 | 0.020 |
Why?
| | Turkey | 1 | 2012 | 22 | 0.020 |
Why?
| | Forecasting | 1 | 2014 | 384 | 0.020 |
Why?
| | London | 1 | 2012 | 47 | 0.020 |
Why?
| | Mental Health | 1 | 2018 | 721 | 0.020 |
Why?
| | Infliximab | 1 | 2012 | 110 | 0.020 |
Why?
| | Needs Assessment | 1 | 2014 | 369 | 0.020 |
Why?
| | Cross-Cultural Comparison | 1 | 2012 | 90 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2012 | 164 | 0.020 |
Why?
| | Biomarkers | 2 | 2013 | 4158 | 0.020 |
Why?
| | Anxiety | 1 | 2018 | 1032 | 0.020 |
Why?
| | United Kingdom | 1 | 2012 | 315 | 0.020 |
Why?
| | Reoperation | 1 | 2013 | 565 | 0.020 |
Why?
| | Immunologic Factors | 1 | 2012 | 237 | 0.020 |
Why?
| | Antirheumatic Agents | 1 | 2012 | 290 | 0.020 |
Why?
| | Risk | 1 | 2012 | 904 | 0.020 |
Why?
| | Models, Organizational | 1 | 2010 | 146 | 0.020 |
Why?
| | Sex Characteristics | 1 | 2014 | 763 | 0.020 |
Why?
| | Aging | 1 | 2018 | 1861 | 0.020 |
Why?
| | Empathy | 1 | 2010 | 168 | 0.020 |
Why?
| | Patient Readmission | 1 | 2013 | 695 | 0.020 |
Why?
| | Holistic Health | 1 | 2007 | 15 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2012 | 1242 | 0.020 |
Why?
| | Learning | 1 | 2010 | 414 | 0.020 |
Why?
| | Sex Factors | 1 | 2012 | 2068 | 0.020 |
Why?
| | CD-ROM | 1 | 2005 | 6 | 0.020 |
Why?
| | Veterans | 1 | 2017 | 1457 | 0.010 |
Why?
| | Diet, Fat-Restricted | 1 | 2005 | 79 | 0.010 |
Why?
| | Computer-Assisted Instruction | 1 | 2005 | 65 | 0.010 |
Why?
| | Nonlinear Dynamics | 1 | 2005 | 87 | 0.010 |
Why?
| | Fruit | 1 | 2005 | 138 | 0.010 |
Why?
| | Registries | 1 | 2012 | 2015 | 0.010 |
Why?
| | Patient Care Planning | 1 | 2005 | 154 | 0.010 |
Why?
| | Vegetables | 1 | 2005 | 155 | 0.010 |
Why?
| | Patient Education as Topic | 1 | 2005 | 760 | 0.010 |
Why?
| | Exercise | 1 | 2005 | 2038 | 0.010 |
Why?
|
|
Bayliss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|